Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Single Dose Two-Way Crossover Fasted Bioequivalence Study of Cetirizine Hydrochloride 10 mg Tablets in Healthy Volunteers

NCT00864279 is registered in ClinicalTrials.gov with Actavis Inc. as lead sponsor.

NCT NCT00864279
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00864279 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Single Dose Two-Way Crossover Fasted Bioequivalence Study of Cetirizine Hydrochloride 10 mg Tablets in Healthy Volunteers
Lead sponsor
Actavis Inc.
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2006
Completion date
September 30, 2006
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy